December 17, 2024 –
Portfolio Category: Prospects
FACIT-71 | Robarts Research Institute (3D ABUS, Dr. A. Fenster)
December 17, 2024 –
Read More from FACIT-71 | Robarts Research Institute (3D ABUS, Dr. A. Fenster)
FACIT-70 | OICR (OHS Breast Cancer Risk, Dr. P. Awadalla)
December 17, 2024 – DNA methylation and breast cancer risk (Ontario Health Study)
Read More from FACIT-70 | OICR (OHS Breast Cancer Risk, Dr. P. Awadalla)
FACIT-40 | Esphera SynBio
August 14, 2024 –
FACIT-69 | Yellowbird Diagnostics Inc.
April 24, 2024 –
FACIT-68 | DTPx Therapeutics (UHN)
December 31, 2023 –
FACIT-67 | Virano Therapeutics
December 22, 2023 –
FACIT-66 | QuAccel (OICR)
May 3, 2023 –
FACIT-65 | HDAX Therapeutics
September 26, 2022 –
FACIT-64 | Hyivy Health
September 26, 2022 –